Conditions: Abdominal Pain
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 197
Healthy volunteers: no

Brief summary:
The primary objective of this pilot study is to assess effects of Hyoscine Butylbromide (HBB) 20 mg in comparison to placebo, when used as needed, as measured by the subject's assessment of intensity of abdominal pain associated with cramping (APC) in the treatment of two episodes.

Detailed description:

Arms:
arm 1: Patient to receive 1-5 tablets containing 20mg HBB per Abdominal pain associated with cramping (APC) episode arm 2: patient to receive a tablet identical to those containing HBB and take 1-5 tablets per episode

Interventions: intervention 1: Placebo intervention 2: HBB 20 mg
Intervention descriptions: intervention 1: 1-5 tablets per episode intervention 2: Active drug, one to five tablets per episode

Protocol document: